# OnCo record nadeno-nanoscience (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nadeno-nanoscience/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nadeno-nanoscience" ;
  schema:name "NaDeNo Nanoscience"@en ;
  schema:alternateName "Nadeno Nanoscience AS"@en, "NaDeNo"@en ;
  schema:description "NaDeNo Nanoscience is a Norwegian company that packs hard-to-dissolve medicines into nanoparticles for delivery where they are needed. Its lead, PACAB-002, puts the chemotherapy cabazitaxel into the abdomen to stop ovarian cancer coming back."@en ;
  schema:url <https://onco.cc/companies/nadeno-nanoscience/>, <https://www.nadeno.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.nadeno.com/>, <https://www.nadeno.com/pacab-002>, <https://www.nadeno.com/news/nadenos-lead-candidate-pacab-002-is-granted-orphan-drug-designation-888bx>, <https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-26-3258> ;
  schema:addressCountry "NO" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/pacab-002/> ;
  onco:terms <https://onco.cc/terms/intraperitoneal-chemotherapy/> .